MICHAEL BRAUN to Antineoplastic Agents
This is a "connection" page, showing publications MICHAEL BRAUN has written about Antineoplastic Agents.
Connection Strength
0.147
-
Maintaining oxaliplatin therapy after hypersensitivity reactions: real-world experience with a desensitisation protocol. Clin Exp Med. 2026 Jan 21; 26(1):118.
Score: 0.118
-
AquIRE reveals the mechanisms of clinically induced RNA damage and the conservation and dynamics of glycoRNAs. Nucleic Acids Res. 2026 Feb 05; 54(4).
Score: 0.030